Form 4: P3 Health Director Granted 2,000 RSUs

P3 Health Partners Inc. Director Gregory D. Wasson was granted 2,000 restricted stock units, aligning his interests with shareholders.

Summary

• Gregory D. Wasson, a Director of P3 Health Partners Inc. (PIII), acquired 2,000 shares of Class A Common Stock.
• The acquisition was a grant of Restricted Stock Units (RSUs) under the P3 Health Partners Inc. 2021 Incentive Award Plan.
• Each RSU represents the right to receive one share of Class A common stock.
• The RSUs were granted on August 6, 2025, at a price of $0 per share.
• The RSUs will vest in one year from the grant date.
• Following this transaction, Gregory D. Wasson directly beneficially owns 218,561 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The filing reports a routine RSU grant to a director, which is a standard compensation practice. It is mildly positive as it aligns the director's interests with shareholders but does not indicate significant new operational or financial developments.

Positives

• The grant of Restricted Stock Units to a director aligns management's long-term interests with those of the shareholders, as the value of the RSUs is tied to the company's stock performance.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged, compliant transaction.

Future Outlook

The granted Restricted Stock Units are scheduled to vest in one year from the grant date, indicating a future increase in the director's vested share count.

Industry Context

The grant of Restricted Stock Units is a common form of equity compensation for directors and executives across various industries, used to incentivize long-term performance and align interests with shareholders. This practice is standard in the healthcare services sector for publicly traded companies.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a compensation mechanism for directors is a standard practice across publicly traded companies, including those in the healthcare sector like P3 Health Partners Inc. (PIII).
• The vesting schedule of one year is a common period for such grants, balancing immediate incentive with long-term retention.
• The grant price of $0 is typical for RSU grants, as they represent a right to receive shares upon vesting, rather than a purchase.

Corporate Governance

Related Party Transactions

• The grant of 2,000 Restricted Stock Units to Gregory D. Wasson, a Director, constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with the long-term performance of the company's stock, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: While not directly impacting employees, the use of equity incentive plans can set a precedent for broader employee compensation strategies.

Next Steps

• The 2,000 Restricted Stock Units granted on August 6, 2025, are expected to vest in one year from that date.

Key Dates

Keywords

P3 Health Partners, PIII, SEC Form 4, Restricted Stock Units, RSU grant, Insider transaction, Director compensation, Equity compensation, Stock ownership